stents

NORDIC-BALTIC IV: 2 stents versus provisional stent in bifurcations

This study aimed to compare the strategy of 2 stents versus provisional stenting in true bifurcations.It was a multicenter, randomized trial included 221 patients in the provisional group and 229 patients in the 2 stent &nbsp;group. No significant differences were observed in the clinical or angiographic characteristics of the two groups (16% diabetic).There were no<a href="https://solaci.org/en/2015/06/24/nordic-baltic-iv-2-stents-versus-provisional-stent-in-bifurcations/" title="Read more" >...</a>

2nd-generation drug-eluting stents, results for “real” patients at two years

Original title:&nbsp;Clinical Outcome Following Stringent Discontinuation of Dual Anti-Platelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: Two-Year Follow-up of the Randomized TWENTE Trial.&nbsp;Reference:&nbsp;Keneth T, Hanim S, et al. J Am Coll Cardiol 2013. Article in press. &nbsp; In recent years there have been new drug-eluting<a href="https://solaci.org/en/2015/06/02/2nd-generation-drug-eluting-stents-results-for-real-patients-at-two-years/" title="Read more" >...</a>

Bioabsorbable stents also in peripheral territory

Original title:&nbsp;Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatmentof De Novo Lesions in the Superficial Femoral Artery. The GAIA Study.&nbsp;Reference:&nbsp;Martin Werner et al. J Am Coll Cardiol Intv 2014;7:305&ndash;12. The aim of this study was to assess the safety and efficacy of the biodegradable stent Igaki-Tamai (Igaki Medical Planning Company, Kyoto, Japan) in<a href="https://solaci.org/en/2015/02/15/bioabsorbable-stents-also-in-peripheral-territory/" title="Read more" >...</a>

Less Definite Thrombosis with Everolimus Eluting Stents

Original title:&nbsp;Three-Year Outcomes After Revascularization With Everolimus-and Sirulimus -Eluting Stents From the SORT OUT IV Trial.&nbsp;Reference:&nbsp;Lisette Okkels Jensen et al. J Am CollCardiolIntv, 2014;7: 840-8. Drug eluting stents (DES) have been shown to safely and effectively reduce restenosis compared to bare-metal stents. While the risk of thrombosis remains a matter of concern when it comes<a href="https://solaci.org/en/2014/08/29/less-definite-thrombosis-with-everolimus-eluting-stents/" title="Read more" >...</a>

Top